S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ASLN ASLAN Pharmaceuticals Ltd

0.60

0.00 (0.00%)

After Hours

Last Updated: 11:00:00

Delayed by 15 minutes

Annual and Transition Report (foreign Private Issuer) (20-f)

This article is 7Mb in size. Click here to view

ASLAN Pharmaceuticals (NASDAQ:ASLN)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more ASLAN Pharmaceuticals Charts.

ASLAN Pharmaceuticals (NASDAQ:ASLN)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more ASLAN Pharmaceuticals Charts.

Aslan Pharmaceuticals Ltd News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 17 July 2024 (8 months ago) • Edgar (US Regulatory)

ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation
Wednesday 17 July 2024 (8 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 15 July 2024 (8 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 15 June 2024 (9 months ago) • Edgar (US Regulatory)

Form F-3 - Registration statement by foreign private issuers
Thursday 13 June 2024 (9 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 1 June 2024 (9 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 9 May 2024 (10 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 7 May 2024 (10 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 11 March 2024 (1 year ago) • Edgar (US Regulatory)

More Aslan Pharmaceuticals Ltd News Articles

Australian SE All Ordina...

JP Morgan Chase

AUD vs US Dollar

Commonwealth Bank Of Aus...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions